Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Trends in Aspirin Use for Secondary Prevention of ASCVD
According to the CDC’s Behavioral Risk Factor Surveillance System 2013, nearly 71% of adults with atherosclerotic cardiovascular disease use aspirin regularly.
Management of Nonsteroidal Anti-inflammatory Drug-Induced Hypersensitivity Reactions
Hypersensitivity symptoms associated with NSAIDs can range from respiratory and/or cutaneous reactions to angioedema.
Peripheral Arterial Disease From a Community Pharmacy Perspective
Peripheral arterial disease (PAD) describes a phenomenon in which circulation to the leg is diminished due to atherosclerosis, resulting in reduced blood flow and often causing pain that can be limiting to those who experience it.
Understanding Cholesterol Therapy: An Update for Community Pharmacists
Elevated total and LDL cholesterol predispose patients to an increased risk of cardiovascular disease and mortality.
Aripiprazole 1 mg/mL Oral Suspension
This may be suitable for patients who cannot take the solid oral dosage forms or tolerate the ingredients in the commercially available oral solution.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.